ScoreComparison
Company
Score
Quality
Valuation
Financial
Technical
Why is Coeptis Therapeutics Holdings, Inc. ?
1
Poor Management Efficiency with a low ROE of 0%
- The company has reported losses. Due to this company has reported negative ROE
2
Positive results in Mar 26
- NET SALES(HY) At USD 0.98 MM has Grown at 1,452.02%
- NET PROFIT(HY) Higher at USD -5.77 MM
- ROCE(HY) Highest at -85.41%
3
Risky -
- The stock is trading risky as compared to its average historical valuations
- Over the past year, while the stock has generated a return of 116.71%, its profits have fallen by -30.6%
4
Increasing Participation by Institutional Investors
- Institutional investors have increased their stake by 3.84% over the previous quarter and collectively hold 17.36% of the company
- These investors have better capability and resources to analyse fundamentals of companies than most retail investors
5
Market Beating Performance
- The stock has generated a return of 116.71% in the last 1 year, much higher than market (S&P 500) returns of 25.41%
Real-Time Research ReportHow much should you hold?
- Overall Portfolio exposure to Coeptis Therapeutics Holdings, Inc. should be less than 10%
- Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is Coeptis Therapeutics Holdings, Inc. for you?
High Risk, High Return
Absolute
Risk Adjusted
Volatility
Coeptis Therapeutics Holdings, Inc.
116.71%
2.31
87.89%
S&P 500
25.41%
1.92
13.25%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
18.74%
EBIT Growth (5y)
-264.29%
EBIT to Interest (avg)
-4.98
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-0.33
Sales to Capital Employed (avg)
0.04
Tax Ratio
0
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
17.36%
ROCE (avg)
0
ROE (avg)
0
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
3.85
EV to EBIT
-4.63
EV to EBITDA
-5.11
EV to Capital Employed
5.41
EV to Sales
44.30
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-116.81%
ROE (Latest)
-77.96%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Sideways
Bullish
Moving Averages
Mildly Bearish (Daily)
KST
Bearish
Bullish
Dow Theory
Mildly Bullish
No Trend
OBV
Mildly Bullish
No Trend
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend16What is working for the Company
NET SALES(HY)
At USD 0.98 MM has Grown at 1,452.02%
NET PROFIT(HY)
Higher at USD -5.77 MM
ROCE(HY)
Highest at -85.41%
RAW MATERIAL COST(Y)
Fallen by -12.61% (YoY
DEBTORS TURNOVER RATIO(HY)
Highest at 184.99 times
-10What is not working for the Company
INTEREST(HY)
At USD 0.45 MM has Grown at 196.93%
OPERATING CASH FLOW(Y)
Lowest at USD -8 MM
Here's what is working for Coeptis Therapeutics Holdings, Inc.
Net Sales
At USD 0.98 MM has Grown at 1,452.02%
Year on Year (YoY)MOJO Watch
Sales trend is very positive
Net Sales (USD MM)
Net Profit
Higher at USD -5.77 MM
than preceding 12 month period ended Mar 2026MOJO Watch
In the half year the company has already crossed Net Profit of the previous twelve months
Net Profit (USD MM)
Debtors Turnover Ratio
Highest at 184.99 times
in the last five Semi-Annual periodsMOJO Watch
Company has been able to sell its Debtors faster
Debtors Turnover Ratio
Raw Material Cost
Fallen by -12.61% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin
Raw Material Cost as a percentage of Sales
Here's what is not working for Coeptis Therapeutics Holdings, Inc.
Interest
At USD 0.45 MM has Grown at 196.93%
over previous Semi-Annual periodMOJO Watch
Rising interest cost signifies increased borrowings
Interest Paid (USD MM)
Operating Cash Flow
Lowest at USD -8 MM
in the last three yearsMOJO Watch
The company's cash revenues from business operations are falling
Operating Cash Flows (USD MM)
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
